Comments

Dynavax Technologies Stock Price, Quotes and Forecasts

Q: What sector and industry does Dynavax Technologies (DVAX) operate in?

Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

DVAXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$13.68

-0.04-0.29%

At close: -

$13.68

0.000.00%

After Hours: Mar 28, 4:00 PM EDT

Dynavax Technologies (DVAX) Forecast

News Earnings Dynavax Technologies (DVAX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Dynavax Technologies Stock Price, Quotes and Forecasts | NASDAQ:DVAX | Benzinga

Explore Dynavax Technologies stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DVAX.

Open	$13.72
Close	$13.68
Volume / Avg.	1.37M / 2.16M
Day Range	$13.53 - $13.80
52 Wk Range	9.74 - 14.63
Market Cap	$1.70B
P/E Ratio	68.60
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	18.89%
Days to Cover	4.86

Recent News

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Goldman Sachs downgraded Dynavax to Sell, citing increased competition in the shingles vaccine market and uncertainty over hepatitis B revaccination demand.

Vandana Singh

This Columbus McKinnon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Avi Kapoor

FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients

Latest regulatory update from Dynavax on HEPLISAV-B vaccine regimen for adults on hemodialysis, with FDA's Complete Response Letter.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$13.72
Close	$13.68
Volume / Avg.	1.37M / 2.16M
Day Range	$13.53 - $13.80
52 Wk Range	9.74 - 14.63
Market Cap	$1.70B
P/E Ratio	68.60
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	18.89%
Days to Cover	4.86

About Dynavax Technologies Corp.

Sector

Health Care

Industry

Biotechnology

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the powe...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Dynavax Technologies (DVAX) stock?

You can purchase shares of Dynavax Technologies (NASDAQ:DVAX) through any online brokerage.

View our list of the best stock brokerages

Who are Dynavax Technologies (DVAX) competitors?

Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Centessa Pharmaceuticals (NASDAQ:CNTA) and Ascentage Pharma Group (NASDAQ:AAPG).

What is the forecast, or price target, for Dynavax Technologies (DVAX) stock?

Dynavax Technologies has a consensus price target of $24.80.

What is the current price for Dynavax Technologies (DVAX)?

The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.68 last updated March 28, 2025 at 4:00 PM EDT.

Does Dynavax Technologies (DVAX) pay a dividend?

There are no upcoming dividends for Dynavax Technologies.

When is Dynavax Technologies (NASDAQ:DVAX) reporting earnings?

Dynavax Technologies’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Dynavax Technologies (DVAX) going to split?

There is no upcoming split for Dynavax Technologies.

What sector and industry does Dynavax Technologies (DVAX) operate in?

Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.